This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Minimizing spending doesn’t have to be a challenge. Explore effortless ways to keep your expenses low while enjoying life.
22,570 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Pre-marketing for homes, dubbed coming soon listings, has moved from niche tests to a nationwide driver of housing de...
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
SoFi Technologies is redefining fintech with a multi-product model that blends digital banking, lending, and crypto. ...
Circle Internet Group stock took a sharp drop as headlines pointed to potential US regulation that could curb stablec...
Robinhood just announced a substantial $1.5 billion buyback. In this analysis, we weigh the potential benefits agains...
As housing markets shift in 2026, Dave Ramsey’s year-long luxury rent strategy is back in focus. This analysis explai...
Base, the Coinbase-backed Ethereum Layer 2, is shifting from optimistic rollups to a zero-knowledge-based finality sy...
In Q1 2026, new homes held prices steady while resale values declined, signaling a pricing strategy where discounts r...
Lenders are adopting a risk-aware approach to growth in 2026, blending disciplined risk controls with cross-functiona...
Space investing has moved from hype to real dollars. This deep dive compares Intuitive Machines and MDA Space to help...
Halozyme’s halo (HALO) 2026 earnings landscape hinges on ENHANZE collaborations, pipeline milestones, and disciplined...